Abstract

IntroductionInduced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) may be suitable for myocardial repair. While their functional and structural properties have been extensively investigated, their response to ischemia-like conditions has not yet been clearly defined.MethodsiPS-CMs were differentiated and enriched from murine induced pluripotent stem cells expressing enhanced green fluorescent protein (eGFP) and puromycin resistance genes under the control of an α-myosin heavy chain (α-MHC) promoter. iPS-CMs maturity and function were characterized by microscopy, real-time PCR, calcium transient recordings, electrophysiology, and mitochondrial function assays, and compared to those from neonatal murine cardiomyocytes. iPS-CMs as well as neonatal murine cardiomyocytes were exposed for 3 hours to hypoxia (1% O2) and glucose/serum deprivation, and viability, apoptosis markers, reactive oxygen species, mitochondrial membrane potential and intracellular stress signaling cascades were investigated. Then, the iPS-CMs response to mesenchymal stromal cell-conditioned medium was determined.ResultsiPS-CMs displayed key morphological and functional properties that were comparable to those of neonatal cardiomyocytes, but several parameters indicated an earlier iPS-CMs maturation stage. During hypoxia and glucose/serum deprivation, iPS-CMs exhibited a significantly higher proportion of poly-caspase-active, 7-aminoactinomycin D-positive and TUNEL-positive cells than neonatal cardiomyocytes. The average mitochondrial membrane potential was reduced in “ischemic” iPS-CMs but remained unchanged in neonatal cardiomyocytes; reactive oxygen species production was only increased in “ischemic” iPS-CMs, and oxidoreductase activity in iPS-CMs dropped more rapidly than in neonatal cardiomyocytes. In iPS-CMs, hypoxia and glucose/serum deprivation led to upregulation of Hsp70 transcripts and decreased STAT3 phosphorylation and total PKCε protein expression. Treatment with mesenchymal stromal cell-conditioned medium preserved oxidoreductase activity and restored pSTAT3 and PKCε levels.ConclusioniPS-CMs appear to be particularly sensitive to hypoxia and nutrient deprivation. Counteracting the ischemic susceptibility of iPS-CMs with mesenchymal stromal cell-conditioned medium may help enhance their survival and efficacy in cell-based approaches for myocardial repair.

Highlights

  • Induced pluripotent stem cell-derived cardiomyocytes may be suitable for myocardial repair

  • We analyzed the response of murine induced pluripotent stem cell (iPS)-CMs and their neonatal murine counterparts (N-CMs) to hypoxia and glucose/serum deprivation (GSD) in vitro, and tested the potential of paracrine factors secreted from bone marrowderived multipotent mesenchymal stromal cell (MSC) to protect induced pluripotent stem cell-derived cardiomyocyte (iPS-CM) from deleterious effects of “simulated in vitro ischemia” [13,14]

  • Cell size was similar between iPS-CMs and neonatal cardiomyocyte (N-CM), and the small percentage of binucleated cells confirmed the relative immaturity of both cell types (Figure 3A-C)

Read more

Summary

Introduction

Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) may be suitable for myocardial repair. While their functional and structural properties have been extensively investigated, their response to ischemia-like conditions has not yet been clearly defined. Transplantation of cardiomyocytes (CMs) into injured myocardium has been shown to improve contractile function in animal models of heart disease [1,2]. A detailed understanding of the cellular response to ischemia-like stress is necessary for improving the efficacy of cell-based myocardial regeneration. And functionally, iPS-CMs were shown to display properties of fetal or neonatal CMs [7,8,9,10]. We analyzed the response of murine iPS-CMs and their neonatal murine counterparts (N-CMs) to hypoxia and glucose/serum deprivation (GSD) in vitro, and tested the potential of paracrine factors secreted from bone marrowderived multipotent MSCs to protect iPS-CMs from deleterious effects of “simulated in vitro ischemia” [13,14]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call